consenso brasileiro Nódulos de Tireóide e Câncer Diferenciado de Tireóide: Consenso Brasileiro

Thyroid nodules are a common manifestation of thyroid diseases. It is estimated that ~10% of adults have palpable thyroid nodules with the frequency increasing throughout life. The major concern on nodule evaluation is the risk of malignancy (5‐10%). Differentiated thyroid carcinoma accounts for 90% of all thyroid malignant neoplasias. Although most patients with cancer have a favorable outcome, some individuals present an aggressive form of the disease and poor prognostic despite recent advances in diagnosis and treatment. Here, a set of clinical guidelines for the evaluation and management of patients with thyroid nodules or differentiated thyroid cancer was developed through consensus by 8 member of the Department of Thyroid, Sociedade Brasileira de Endocrinologia e Metabologia. The participants are from different reference medical centers within Brazil, to reflect different practice patterns. Each committee participant was initially assigned to write a section of the document and to submit it to the chairperson, who revised and assembled the sections into a complete draft document, which was then circulated among all committee members for further revision. All committee members further revised and refined the document. The guidelines were developed based on the expert opinion of the committee participants, as well as on previously published information. (Arq Bras Endocrinol Metab 2007;51/5:867-893)

[1]  T. Sebo,et al.  Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. , 2008, Surgery.

[2]  Á. Barroso,et al.  Positive predictive value of detectable stimulated tg during the first year after therapy of thyroid cancer and the value of comparison with Tg-ablation and Tg measured after 24 months. , 2006, Thyroid : official journal of the American Thyroid Association.

[3]  J. Franklyn,et al.  Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. , 2006, The Journal of clinical endocrinology and metabolism.

[4]  L. Scapozza,et al.  Inhibition of RET tyrosine kinase by SU5416. , 2006, Journal of molecular endocrinology.

[5]  Jung Hun Song,et al.  An orally administered multitarget tyrosine kinase inhibitor, SU11248, is a novel potent inhibitor of thyroid oncogenic RET/papillary thyroid cancer kinases. , 2006, The Journal of clinical endocrinology and metabolism.

[6]  S. Larson,et al.  Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  Saulo Purisch,et al.  Seguimento de pacientes de alto risco com carcinoma diferenciado de tireóide sem doença persistente após a terapia inicial , 2006 .

[8]  L. Bartalena,et al.  Surgery of lymph nodes in papillary thyroid cancer , 2006, Expert review of anticancer therapy.

[9]  A. Elias,et al.  Enhanced Radioiodine Uptake in a Patient With Poorly Differentiated Papillary Thyroid Cancer After Treatment With Rosiglitazone , 2006, Clinical nuclear medicine.

[10]  R. Hicks,et al.  Management of paediatric thyroid carcinoma: recent experience with recombinant human thyroid stimulating hormone in preparation for radioiodine therapy , 2006, Internal medicine journal.

[11]  V. Guimarães,et al.  Testicular function after radioiodine therapy in patients with thyroid cancer. , 2006, Thyroid : official journal of the American Thyroid Association.

[12]  G. Mariani,et al.  Recombinant human thyroid-stimulating hormone is effective for radioiodine ablation of post-surgical thyroid remnants , 2006, Nuclear medicine communications.

[13]  J. Kievit,et al.  Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies , 2006, Clinical endocrinology.

[14]  G. Palù,et al.  Clinical trials of gene therapy, virotherapy, and immunotherapy for malignant gliomas , 2006, Cancer Gene Therapy.

[15]  E. Chin,et al.  Thyroid Surgery: Changing Patterns of Practice , 2006, The Laryngoscope.

[16]  W. Wiersinga,et al.  European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. , 2006, European journal of endocrinology.

[17]  R. Kloos,et al.  Phase II study of celecoxib in metastatic differentiated thyroid carcinoma. , 2006, The Journal of clinical endocrinology and metabolism.

[18]  Rosalinda Camargo,et al.  Câncer diferenciado da tiróide de baixo risco: revisão do estado atual da literatura e proposta de conduta , 2006 .

[19]  E. Mazzaferri Managing small thyroid cancers. , 2006, JAMA.

[20]  P. Ladenson,et al.  Well-differentiated epithelial thyroid cancer management in the Asia Pacific region: a report and clinical practice guideline. , 2006, Thyroid : official journal of the American Thyroid Association.

[21]  A. Pontecorvi,et al.  Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: A multicenter study , 2006, Journal of endocrinological investigation.

[22]  S. Mariotti,et al.  The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies. , 2006, The Journal of clinical endocrinology and metabolism.

[23]  J. Fagin,et al.  Inhibitors of Raf Kinase Activity Block Growth of Thyroid Cancer Cells with RET/PTC or BRAF Mutations In vitro and In vivo , 2006, Clinical Cancer Research.

[24]  R. Kloos,et al.  Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2006, Thyroid : official journal of the American Thyroid Association.

[25]  R. Wahl,et al.  Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. , 2006, The Journal of clinical endocrinology and metabolism.

[26]  M. Santoro,et al.  BRAF Is a Therapeutic Target in Aggressive Thyroid Carcinoma , 2006, Clinical Cancer Research.

[27]  P. Hall,et al.  Clinically significant prognostic factors for differentiated thyroid carcinoma , 2006, Cancer.

[28]  V. Guimarães,et al.  Radioiodine therapy and age at menopause in patients with thyroid cancer , 2006, Clinical endocrinology.

[29]  V. Guimarães,et al.  Managing thyroid cancer without thyroxine withdrawal. , 2006, Arquivos brasileiros de endocrinologia e metabologia.

[30]  J. Mccaffrey Aerodigestive Tract Invasion by Well‐Differentiated Thyroid Carcinoma: Diagnosis, Management, Prognosis, and Biology , 2006, The Laryngoscope.

[31]  A. Chrisoulidou,et al.  Cerebellar metastasis as first metastasis from papillary thyroid carcinoma. , 2005, Endocrine journal.

[32]  Q. Duh,et al.  Valproic acid inhibits growth, induces apoptosis, and modulates apoptosis-regulatory and differentiation gene expression in human thyroid cancer cells. , 2005, Surgery.

[33]  M. Castellano,et al.  Is the anteroposterior and transverse diameter ratio of nonpalpable thyroid nodules a sonographic criteria for recommending fine‐needle aspiration cytology? , 2005, Clinical endocrinology.

[34]  C. Ahn,et al.  Clinical features of bone metastases resulting from thyroid cancer: a review of 28 patients over a 20-year period. , 2005, Endocrine journal.

[35]  Á. Barroso,et al.  Ultrasonographic Differentiation Between Metastatic and Benign Lymph Nodes in Patients With Papillary Thyroid Carcinoma , 2005, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[36]  C. Spencer,et al.  Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas. , 2005, The Journal of clinical endocrinology and metabolism.

[37]  E. Baudin,et al.  Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. , 2005, The Journal of clinical endocrinology and metabolism.

[38]  J. L. Gross,et al.  Carcinoma diferenciado de tireide: avaliao inicial e acompanhamento , 2005 .

[39]  C. Coeli,et al.  [Incidence and mortality from thyroid cancer in Brazil]. , 2005, Arquivos brasileiros de endocrinologia e metabologia.

[40]  E. Mazzaferri Empirically treating high serum thyroglobulin levels. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[41]  V. Guimarães,et al.  Ovarian function after radioiodine therapy in patients with thyroid cancer. , 2005, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[42]  H. Fideleff,et al.  Repeated fine-needle aspiration of the thyroid in benign nodular thyroid disease: critical evaluation of long-term follow-up. , 2005, Thyroid : official journal of the American Thyroid Association.

[43]  G. Kovacs,et al.  Epidemiology of thyroid microcarcinoma found in autopsy series conducted in areas of different iodine intake. , 2005, Thyroid : official journal of the American Thyroid Association.

[44]  M. Luster,et al.  rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review. , 2005, Endocrine-related cancer.

[45]  P. Cohan,et al.  Successful use of recombinant human thyrotropin in the therapy of pediatric well-differentiated thyroid cancer , 2005, Journal of endocrinological investigation.

[46]  N. Tamaki,et al.  Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer? , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[47]  V. Guimarães,et al.  Thyroglobulin before Ablation and Correlation with Posttreatment Scanning , 2005, The Laryngoscope.

[48]  David Goldenberg,et al.  The Role of Positron Emission Tomography/Computed Tomography in the Management of Recurrent Papillary Thyroid Carcinoma , 2005, The Laryngoscope.

[49]  Pedro Wesley Souza Do Rosário,et al.  Post I-131 Therapy Scanning in Patients With Thyroid Carcinoma Metastases: An Unnecessary Cost or a Relevant Contribution? , 2004, Clinical nuclear medicine.

[50]  Rosalinda Camargo,et al.  Avaliação ultra-sonográfica da tireóide e determinação da iodúria em escolares de diferentes regiões do Estado de São Paulo , 2004 .

[51]  A. Atri,et al.  Thyroid nodule shape and prediction of malignancy. , 2004, Thyroid : official journal of the American Thyroid Association.

[52]  H. Baskin Detection of recurrent papillary thyroid carcinoma by thyroglobulin assessment in the needle washout after fine-needle aspiration of suspicious lymph nodes. , 2004, Thyroid : official journal of the American Thyroid Association.

[53]  H. Yamashita,et al.  Modified Radical Neck Dissection for Differentiated Thyroid Cancer: Operative Technique , 2004, World Journal of Surgery.

[54]  G. Thompson,et al.  Current Strategies for Surgical Management and Adjuvant Treatment of Childhood Papillary Thyroid Carcinoma , 2004, World Journal of Surgery.

[55]  Á. Barroso,et al.  Efficacy of low and high 131I doses for thyroid remnant ablation in patients with differentiated thyroid carcinoma based on post-operative cervical uptake , 2004, Nuclear medicine communications.

[56]  M. Santoro,et al.  Identification of RET Kinase Inhibitors as Potential New Treatment for Sporadic and Inherited Thyroid Cancer , 2004, Journal of chemotherapy.

[57]  L. Hegedüs,et al.  The Thyroid Nodule , 2004 .

[58]  J. Montes,et al.  Iodine nutrition improves in Latin America. , 2004, Thyroid : official journal of the American Thyroid Association.

[59]  T. A. Fagundes,et al.  Antithyroglobulin antibodies in patients with differentiated thyroid carcinoma: methods of detection, interference with serum thyroglobulin measurement and clinical significance. , 2004, Arquivos brasileiros de endocrinologia e metabologia.

[60]  R. Maciel Ainda em busca do ensaio ideal para a tiroglobulina sérica no seguimento de pacientes com câncer diferenciado da tiróide , 2004 .

[61]  H. Gerstein,et al.  A Systematic Review and Metaanalysis of the Effectiveness of Radioactive Iodine Remnant Ablation for Well-Differentiated Thyroid Cancer , 2004 .

[62]  J. Hennessey,et al.  Two-week low iodine diet is necessary for adequate outpatient preparation for radioiodine rhTSH scanning in patients taking levothyroxine. , 2004, Thyroid : official journal of the American Thyroid Association.

[63]  N. Avenia,et al.  Locally advanced thyroid cancer: therapeutic options. , 2004, Chirurgia italiana.

[64]  L. Kowalski,et al.  Postoperative complications of thyroidectomy for differentiated thyroid carcinoma. , 2004, American journal of otolaryngology.

[65]  Sebastiano Filetti,et al.  Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases. , 2004, The Journal of clinical endocrinology and metabolism.

[66]  P. Arveux,et al.  Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after (131)I ablation therapy in patients with differentiated thyroid cancer. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[67]  A. Miyauchi,et al.  Preoperative Ultrasonographic Examination for Lymph Node Metastasis: Usefulness when Designing Lymph Node Dissection for Papillary Microcarcinoma of the Thyroid , 2004, World Journal of Surgery.

[68]  C. Bal,et al.  Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: a randomized clinical trial in 509 patients. , 2004, The Journal of clinical endocrinology and metabolism.

[69]  A. Buescu,et al.  Retinoic acid in patients with radioiodine non-responsive thyroid carcinoma , 2004, Journal of endocrinological investigation.

[70]  T. Montesano,et al.  Lung metastases from differentiated thyroid carcinoma. A 40 years' experience. , 2004, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[71]  L. Ward,et al.  [Thyroid cancer: prognostic factors and treatment]. , 2004, Arquivos brasileiros de endocrinologia e metabologia.

[72]  G. Medeiros-Neto,et al.  [Ultrasonographic evaluation of thyroid nodules: comparison with cytologic and histologic diagnosis]. , 2004, Arquivos brasileiros de endocrinologia e metabologia.

[73]  J. H. Romaldini,et al.  [Subclinical thyroid disease: subclinical hypothyroidism and hyperthyroidism]. , 2004, Arquivos brasileiros de endocrinologia e metabologia.

[74]  J. Franklyn,et al.  Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. , 2004, JAMA.

[75]  Bruno D Fornage,et al.  Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. , 2003, Surgery.

[76]  P. Hall,et al.  Second primary malignancies in thyroid cancer patients , 2003, British Journal of Cancer.

[77]  Seung-Yong Jeong,et al.  Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. , 2003, The Journal of clinical endocrinology and metabolism.

[78]  J. Shah,et al.  Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma. , 2003, Journal of the American College of Surgeons.

[79]  A. Pinchera,et al.  Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. , 2003, The Journal of clinical endocrinology and metabolism.

[80]  J. Buckner,et al.  Management of brain metastases from thyroid carcinoma , 2003, Cancer.

[81]  J. Chan,et al.  Papillary microcarcinoma of the thyroid—Prognostic significance of lymph node metastasis and multifocality , 2003, Cancer.

[82]  F. Biancari,et al.  Predictors of outcome for patients with differentiated and aggressive thyroid carcinoma. , 2003, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement.

[83]  J. Romijn,et al.  Outcome of palliative embolization of bone metastases in differentiated thyroid carcinoma. , 2003, The Journal of clinical endocrinology and metabolism.

[84]  J. Romijn,et al.  Effects of low‐iodide diet on postsurgical radioiodide ablation therapy in patients with differentiated thyroid carcinoma , 2003, Clinical endocrinology.

[85]  Stephanie L. Lee,et al.  A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. , 2003, The Journal of clinical endocrinology and metabolism.

[86]  Koichi Ito,et al.  Lymph Node Metastasis From 259 Papillary Thyroid Microcarcinomas: Frequency, Pattern of Occurrence and Recurrence, and Optimal Strategy for Neck Dissection , 2003, Annals of surgery.

[87]  S. Mandel,et al.  Radioactive iodine and the salivary glands. , 2003, Thyroid : official journal of the American Thyroid Association.

[88]  E. Baudin,et al.  Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients. , 2003, The Journal of clinical endocrinology and metabolism.

[89]  L. Hegedüs,et al.  A prospective study of thyroid function, morphology and autoimmunity in young patients with type 1 diabetes. , 2003, European journal of endocrinology.

[90]  C. Ginter,et al.  The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance. , 2003, Endocrine reviews.

[91]  S. Libutti,et al.  Role of metastasectomy in the management of thyroid carcinoma: The NIH experience , 2003, Journal of surgical oncology.

[92]  P. Caron,et al.  Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group. , 2002, The Journal of clinical endocrinology and metabolism.

[93]  P. Caraballo,et al.  Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis. , 2002, The Journal of clinical endocrinology and metabolism.

[94]  A. Oberg,et al.  Papillary Thyroid Carcinoma Managed at the Mayo Clinic during Six Decades (1940–1999): Temporal Trends in Initial Therapy and Long-term Outcome in 2444 Consecutively Treated Patients , 2002, World Journal of Surgery.

[95]  D. Lee,et al.  Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation , 2002, Clinical endocrinology.

[96]  Q. Duh,et al.  Complications of Neck Dissection for Thyroid Cancer , 2002, World Journal of Surgery.

[97]  C. Harmer,et al.  Testicular dose and fertility in men following I131 therapy for thyroid cancer , 2002, Clinical endocrinology.

[98]  C. Compton,et al.  TNM residual tumor classification revisited , 2002, Cancer.

[99]  Anna Crescenzi,et al.  Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. , 2002, The Journal of clinical endocrinology and metabolism.

[100]  A. Pinchera,et al.  Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment. , 2002, The Journal of clinical endocrinology and metabolism.

[101]  M. Sonenberg Low-iodine diet in the treatment of differentiated thyroid cancer with radioactive iodine , 2002, Endocrine.

[102]  G. Zettinig,et al.  Long‐term follow‐up of patients with bone metastases from differentiated thyroid carcinoma – surgery or conventional therapy? , 2002, Clinical endocrinology.

[103]  C. Harmer,et al.  Prognosis for fertility and ovarian function after treatment with radioiodine for thyroid cancer , 2002, Postgraduate medical journal.

[104]  M. Knobel,et al.  Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer , 2002, Journal of endocrinological investigation.

[105]  G. Csako,et al.  Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer , 2002, Annals of medicine.

[106]  S. Larson,et al.  Resistance of [18f]-fluorodeoxyglucose-avid metastatic thyroid cancer lesions to treatment with high-dose radioactive iodine. , 2001, Thyroid : official journal of the American Thyroid Association.

[107]  R. Vigneri,et al.  Usefulness of recombinant human thyrotropin in the radiometabolic treatment of selected patients with thyroid cancer. , 2001, Thyroid : official journal of the American Thyroid Association.

[108]  E. Koike,et al.  Bronchoscopic diagnosis of thyroid cancer with laryngotracheal invasion. , 2001, Archives of surgery.

[109]  P. Merlet,et al.  Clinical impact of (18)F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative (131)I scanning results after therapy. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[110]  A. Pinchera,et al.  Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: comparison of patients treated with high (131)I activities versus untreated patients. , 2001, The Journal of clinical endocrinology and metabolism.

[111]  G. Braunstein,et al.  Reevaluation of the impact of a stringent low-iodine diet on ablation rates in radioiodine treatment of thyroid carcinoma. , 2001, Thyroid : official journal of the American Thyroid Association.

[112]  N. Sarlis Metastatic thyroid cancer unresponsive to conventional therapies: novel management approaches through translational clinical research. , 2001, Current drug targets. Immune, endocrine and metabolic disorders.

[113]  Amy Y. Chen,et al.  The development of breast carcinoma in women with thyroid carcinoma , 2001, Cancer.

[114]  S. Manolidis,et al.  Thyroid Surgery: A Comparison of Outcomes between Experts and Surgeons in Training , 2001, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[115]  A. Jennings Evaluation of substernal goiters using computed tomography and MR imaging. , 2001, Endocrinology and metabolism clinics of North America.

[116]  A. Abbruzzese,et al.  Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer , 2001, British Journal of Cancer.

[117]  R. Solans,et al.  Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[118]  G. Hejblum,et al.  Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. , 2001, The Journal of clinical endocrinology and metabolism.

[119]  R. Kloos,et al.  Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer , 2001 .

[120]  S. Mandel,et al.  Usefulness of Ultrasonography in the Management of Nodular Thyroid Disease , 2000, Annals of Internal Medicine.

[121]  Christopher Wong,et al.  Thyroid Nodules: Rational Management , 2000, World Journal of Surgery.

[122]  J. Pasieka Hashimoto's Disease and Thyroid Lymphoma: Role of the Surgeon , 2000, World Journal of Surgery.

[123]  J. Shah,et al.  Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996 , 2000, Cancer.

[124]  A. King,et al.  Staging papillary carcinoma of the thyroid: magnetic resonance imaging vs ultrasound of the neck. , 2000, Clinical radiology.

[125]  B. Weintraub,et al.  A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. , 1999, The Journal of clinical endocrinology and metabolism.

[126]  I. Fleming,et al.  A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985‐1995 , 1998, Cancer.

[127]  A. Akdoğan,et al.  Value of re-aspirations in benign nodular thyroid disease. , 1998, Thyroid : official journal of the American Thyroid Association.

[128]  T. Ishigaki,et al.  Preoperative staging of thyroid papillary carcinoma with ultrasonography. , 1998, European journal of radiology.

[129]  J. Gross,et al.  Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses. , 1998, The Journal of clinical endocrinology and metabolism.

[130]  P. Ladenson,et al.  Outcome after Treatment of High-Risk Papillary and Non-Hurthle-Cell Follicular Thyroid Carcinoma , 1998, Annals of Internal Medicine.

[131]  B Nygaard,et al.  Observer variation in the clinical and laboratory evaluation of patients with thyroid dysfunction and goiter. , 1998, Thyroid : official journal of the American Thyroid Association.

[132]  F. Rath,et al.  Pattern of lymph node metastases in papillary thyroid carcinoma , 1998, The British journal of surgery.

[133]  M. Schlumberger,et al.  Papillary and follicular thyroid carcinoma. , 1998, The New England journal of medicine.

[134]  H. Gharib,et al.  Changing concepts in the diagnosis and management of thyroid nodules. , 1997, Endocrinology and metabolism clinics of North America.

[135]  S. Sherman,et al.  Prognosis and treatment of brain metastases in thyroid carcinoma. , 1997, The Journal of clinical endocrinology and metabolism.

[136]  E. Mazzaferri,et al.  Outcome of differentiated thyroid cancer diagnosed in pregnant women. , 1997, The Journal of clinical endocrinology and metabolism.

[137]  E. Baudin,et al.  131I therapy for elevated thyroglobulin levels. , 1997, Thyroid : official journal of the American Thyroid Association.

[138]  R. Hoover,et al.  Solid cancers after bone marrow transplantation. , 1997, The New England journal of medicine.

[139]  P. Caron,et al.  Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group. , 1997, The Journal of clinical endocrinology and metabolism.

[140]  H. Gharib,et al.  Thyroid Incidentalomas: Management Approaches to Nonpalpable Nodules Discovered Incidentally on Thyroid Imaging , 1997, Annals of Internal Medicine.

[141]  B. Uzzan,et al.  Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. , 1996, The Journal of clinical endocrinology and metabolism.

[142]  P. Ladenson,et al.  Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. , 1996, Archives of internal medicine.

[143]  B. Nilsson,et al.  Improved Survival of Patients with Papillary Thyroid Cancer after Surgical Microdissection , 1996, World Journal of Surgery.

[144]  P. Ladenson,et al.  Diagnostic accuracy of 131I scanning with recombinant human thyrotropin versus thyroid hormone withdrawal in a patient with metastatic thyroid carcinoma and hypopituitarism. , 1996, The Journal of clinical endocrinology and metabolism.

[145]  M. Schlumberger,et al.  Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[146]  A. Pinchera,et al.  Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[147]  H. Burch,et al.  Evaluation and management of the solid thyroid nodule. , 1995, Endocrinology and metabolism clinics of North America.

[148]  K. Ain,et al.  Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan. , 1995, The Journal of clinical endocrinology and metabolism.

[149]  R. D'Agostino,et al.  Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. , 1994, The New England journal of medicine.

[150]  S. Jhiang,et al.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. , 1994, The American journal of medicine.

[151]  A. Pinchera,et al.  Testicular function in patients with differentiated thyroid carcinoma treated with radioiodine. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[152]  S Chagnon,et al.  The diagnostic value of fine-needle aspiration biopsy under ultrasonography in nonfunctional thyroid nodules: a prospective study comparing cytologic and histologic findings. , 1994, The American journal of medicine.

[153]  D. Casara,et al.  Clinical meaning of circulating antithyroglobulin antibodies in differentiated thyroid cancer: a prospective study. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[154]  A. Pinchera,et al.  Detection of thyroglobulin in fine needle aspirates of nonthyroidal neck masses: a clue to the diagnosis of metastatic differentiated thyroid cancer. , 1992, The Journal of clinical endocrinology and metabolism.

[155]  V S Hertzberg,et al.  Radioiodine-131 therapy for well-differentiated thyroid cancer--a quantitative radiation dosimetric approach: outcome and validation in 85 patients. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[156]  Howard S. Smith,et al.  Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer. , 1990, Endocrinology and metabolism clinics of North America.

[157]  K. Robbins,et al.  Metastatic papillary carcinoma of the thyroid: The significance of extranodal extension , 1989, Head & neck.

[158]  J. Norton,et al.  A Simplified Low Iodine Diet in I-131 Scanning and Therapy of Thyroid Cancer , 1988, Clinical nuclear medicine.

[159]  A. Pinchera,et al.  Serum thyroglobulin in thyroid carcinoma and other thyroid disorders , 1980, Journal of endocrinological investigation.

[160]  D. Appleton,et al.  THE SPECTRUM OF THYROID DISEASE IN A COMMUNITY: THE WHICKHAM SURVEY , 1977, Clinical endocrinology.

[161]  G. Shambaugh,et al.  Disparate thyroid imaging. Combined studies with sodium pertechnetate Tc 99m and radioactive iodine. , 1974, JAMA.

[162]  C. Hill,et al.  Chemotherapy of thyroid cancer with adriamycin. Experience with 30 patients. , 1974, The New England journal of medicine.

[163]  C. Hill,et al.  Chemotherapy of thyroid cancer. An evaluation of experience with 37 patients , 1972, Cancer.

[164]  E. A. Gaston,et al.  The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. , 1968, Annals of internal medicine.

[165]  T. P. Fox,et al.  Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human tsh-stimulated thyroglobulin in follow-up of thyroid cancer patients. , 2007, The Journal of clinical endocrinology and metabolism.

[166]  Matthew J Hayat,et al.  Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. , 2007, The oncologist.

[167]  J. Franklyn,et al.  131I activity for remnant ablation in patients with differentiated thyroid cancer: A systematic review. , 2007, The Journal of clinical endocrinology and metabolism.

[168]  L. Ward,et al.  Prevalence of papillary microcarcinoma of the thyroid in Brazilian autopsy and surgical series , 2006, Endocrine pathology.

[169]  E. Pearce,et al.  Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. , 2006, The Journal of clinical endocrinology and metabolism.

[170]  E. Baudin,et al.  Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. , 2006, The Journal of clinical endocrinology and metabolism.

[171]  A. Di Giorgio,et al.  Comparative evaluation of recombinant human thyrotropin-stimulated thyroglobulin levels, 131I whole-body scintigraphy, and neck ultrasonography in the follow-up of patients with papillary thyroid microcarcinoma who have not undergone radioiodine therapy. , 2006, The Journal of clinical endocrinology and metabolism.

[172]  R. Kloos,et al.  A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later. , 2005, The Journal of clinical endocrinology and metabolism.

[173]  R. Wahl,et al.  Recombinant human thyrotropin stimulation of fluoro-D-glucose positron emission tomography uptake in well-differentiated thyroid carcinoma. , 2004, The Journal of clinical endocrinology and metabolism.

[174]  A. Pinchera,et al.  Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. , 2004, The Journal of clinical endocrinology and metabolism.

[175]  T. Furlanetto,et al.  Ultrasonography: Is it useful in the diagnosis of cancer in thyroid nodules? , 2002, Journal of endocrinological investigation.

[176]  R. Hinze,et al.  Pattern of Nodal Metastasis for Primary and Reoperative Thyroid Cancer , 2002, World journal of surgery.

[177]  A. Pinchera,et al.  Radioiodine treatment of metastatic differentiated thyroid cancer in patients on L-thyroxine, using recombinant human TSH. , 2001, European journal of endocrinology.

[178]  E. Baudin,et al.  Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? , 2000, The Journal of clinical endocrinology and metabolism.

[179]  B. Haugen Management of the patient with progressive radioiodine non-responsive disease. , 1999, Seminars in surgical oncology.

[180]  A. Pontecorvi,et al.  Diagnostic accuracy of conventional versus sonography-guided fine-needle aspiration biopsy of thyroid nodules. , 1998, Thyroid : official journal of the American Thyroid Association.

[181]  P. Ladenson,et al.  Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. , 1998, Thyroid : official journal of the American Thyroid Association.

[182]  I. Hay,et al.  Thyroid cancer nodal metastases: biologic significance and therapeutic considerations. , 1996, Surgical oncology clinics of North America.

[183]  E. Bergstralh,et al.  Papillary thyroid microcarcinoma : a study of 535 cases observed in a 50-year period: Discussion , 1992 .

[184]  L. Davies,et al.  Increasing incidence of thyroid cancer in the United States, 1973-2002. , 2006, JAMA.